SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vasomedical Inc.
VASO 0.170+9.7%Dec 5 2:48 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Abe Bleich who wrote (752)11/18/1997 10:45:00 AM
From: TradeOfTheDay  Read Replies (1) of 1605
 
Abe, I'm not arguing against EECP. I see it as a valuable therapy.
I must tell you that this stock was recommended to me by a CV surgeon. He does not see it as a threat - he thinks it is a wonderful concept. I don't think the studies have been in place long enough to prove exactly how much collateral circulation it increases. And as I said before , even if it does - collaterals take a long time to generate. Many patients don't have that long to wait..... they will still be surgical candidates. ASCVD takes place over many, many years- not an easily reversible process.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext